We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$1.88B
AUM Growth
+$96.1M
Cap. Flow
+$21.6M
Cap. Flow %
1.15%
Top 10 Hldgs %
23.84%
Holding
447
New
26
Increased
115
Reduced
94
Closed
18

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$68.8M
2
BIIB icon
Biogen
BIIB
+$9.22M
3
MSFT icon
Microsoft
MSFT
+$8.34M
4
STZ icon
Constellation Brands
STZ
+$8.05M
5
VLO icon
Valero Energy
VLO
+$5.74M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Technology 20.98%
3 Consumer Discretionary 13.94%
4 Financials 9.85%
5 Communication Services 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
101
Xylem
XYL
$27.3B
$4.83M 0.26%
59,000
CSGP icon
102
CoStar Group
CSGP
$12B
$4.75M 0.25%
85,670
-34,330
-29% -$1.75M
TERP
103
DELISTED
TerraForm Power, Inc
TERP
$4.73M 0.25%
335,390
+65,000
+24% +$893K
NKTR icon
104
Nektar Therapeutics
NKTR
$2.41B
$4.7M 0.25%
9,033
+1,313
+17% +$658K
ECL icon
105
Ecolab
ECL
$78.6B
$4.65M 0.25%
24,190
+9,200
+61% +$1.71M
CRM icon
106
Salesforce
CRM
$148B
$4.61M 0.24%
30,590
+8,950
+41% +$1.4M
ZGNX
107
DELISTED
Zogenix, Inc.
ZGNX
$4.53M 0.24%
94,900
+55,000
+138% +$2.21M
ALNY icon
108
Alnylam Pharmaceuticals
ALNY
$27.4B
$4.49M 0.24%
63,100
BPMC
109
DELISTED
Blueprint Medicines
BPMC
$4.41M 0.23%
47,600
+13,200
+38% +$1.09M
BLUE
110
DELISTED
bluebird bio
BLUE
$4.4M 0.23%
2,744
-271
-9% -$469K
JPM icon
111
JPMorgan Chase
JPM
$933B
$4.38M 0.23%
39,615
-500
-1% -$55.1K
PNC icon
112
PNC Financial Services
PNC
$99.2B
$4.32M 0.23%
31,961
-386
-1% -$51K
GWPH
113
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.17M 0.22%
24,500
+7,000
+40% +$1.21M
CMCSA icon
114
Comcast
CMCSA
$84B
$4.13M 0.22%
97,935
+10,854
+12% +$458K
IONS icon
115
Ionis Pharmaceuticals
IONS
$8.81B
$4.09M 0.22%
63,200
+15,200
+32% +$1.07M
EXEL icon
116
Exelixis
EXEL
$14.1B
$4.01M 0.21%
186,800
+10,600
+6% +$222K
MFC icon
117
Manulife Financial
MFC
$74B
$3.96M 0.21%
217,400
+13,100
+6% +$233K
LNC icon
118
Lincoln National
LNC
$8.8B
$3.92M 0.21%
61,270
-900
-1% -$57.5K
ICE icon
119
Intercontinental Exchange
ICE
$88.4B
$3.81M 0.2%
44,740
+3,006
+7% +$245K
SEDG icon
120
SolarEdge
SEDG
$2.54B
$3.72M 0.2%
61,000
-6,000
-9% -$303K
MDLZ icon
121
Mondelez International
MDLZ
$80.5B
$3.65M 0.19%
67,415
+4,045
+6% +$210K
SGEN
122
DELISTED
Seagen Inc. Common Stock
SGEN
$3.64M 0.19%
54,150
+3,400
+7% +$238K
SCHW
123
Charles Schwab
SCHW
$181B
$3.63M 0.19%
+91,133
New +$3.97M
ONC
124
BeOne Medicines Ltd
ONC
$33.4B
$3.47M 0.18%
27,600
GBT
125
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.44M 0.18%
63,800
+34,800
+120% +$2M

Similar funds

Erste Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Erste Asset Management held 447 positions worth $1.88B, up 5.4% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Erste Asset Management's Q2 2019 filing shows 26 new, 115 increased, 94 reduced and 18 closed positions. Its largest new stake was Foot Locker: 600,000 shares worth $25.2M. The largest sale was Celgene Corp, an estimated $68.8M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2019 buy was Foot Locker: 600,000 shares worth $25.2M.
  • Erste Asset Management added most to Bristol-Myers Squibb in Q2 2019, an estimated $24.6M increase.
  • Erste Asset Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $68.8M.
  • Erste Asset Management fully exited Scotiabank in Q2 2019, selling an estimated $1.55M.
  • Erste Asset Management's ten largest holdings make up 24% of its $1.88B portfolio in Q2 2019.
  • Erste Asset Management opened 26 new positions and closed 18 in Q2 2019.
  • Erste Asset Management's portfolio value rose 5.4% quarter-over-quarter to $1.88B.

Based on Erste Asset Management's 13F filing for Q2 2019, filed 22 Nov 2024.